Exploring the Structure-Activity Relationships of Albumin-Targeted Picoplatin-Based Platinum(IV) ProdrugsINORGANIC CHEMISTRYIF4.72025-01-290OAAI
Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugsINORGANIC CHEMISTRY FRONTIERSIF6.42024-01-016OAAI
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugsINORGANIC CHEMISTRY FRONTIERSIF6.42023-01-0118OAAI
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistanceCOMMUNICATIONS CHEMISTRYIF6.22022-04-0642OAAI
Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating LigandsJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-08-1734OAAI
Improving the Stability of Maleimide-Thiol Conjugation for Drug TargetingCHEMISTRY-A EUROPEAN JOURNALIF3.72020-10-2746OAAI
A Dogma in Doubt: Hydrolysis of Equatorial Ligands of PtIV Complexes under Physiological ConditionsANGEWANDTE CHEMIE-INTERNATIONAL EDITIONIF16.92019-04-2548OAAI
Comparative Evaluation of Thiol- and Amine-Conjugating Moieties for Endogenous Albumin Binding after Intravenous Administration静脉给药后硫醇基和胺基结合基团与内源性白蛋白结合的对比评估ACS Pharmacology & Translational ScienceIF3.70OA
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向